Rethinking the governance of human embryo research in the face of scientific advances — ASN Events
  1. Schedule
  2. Joint Poster Session
  3. Rethinking the governance of human embryo research in the face of scientific advances

Rethinking the governance of human embryo research in the face of scientific advances (#501)

Narcyz Ghinea 1 , Christopher Rudge 2 , Dianne Nicol 3 , Tamra Lysaght 1 4
  1. Sydney Health Ethics, Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
  2. Sydney Law School, University of Sydney, Sydney, New South Wales, Australia
  3. Centre for Law and Genetics, School of Law, University of Tasmania, Hobart, TASMANIA, Australia
  4. Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Background:
Australia’s human embryo research legislation has remained largely unchanged since its last comprehensive review in 2011, despite rapid advances in developmental biology and stem cell science. Emerging technologies, including stem cell-based embryo models (SCEMs) and improved embryo culture techniques capable of supporting development beyond current limits, challenge the adequacy of existing regulatory frameworks. This paper presents the case for formal review of Australia’s laws and examines whether reform is warranted.

Methods:
A policy and ethics analysis of Australia’s legislative framework for embryo research, including the Research Involving Human Embryos Act 2002 and Prohibition of Human Cloning for Reproduction Act 2002. Relevant regulatory guidance, decisions of the NHMRC Embryo Research Licensing Committee, and national and international literature on SCEMs, the 14-day rule, and public attitudes were also reviewed.

Results:
Scientific advances have exposed ambiguities in the legal definition of a human embryo, particularly regarding the regulatory status of different SCEMs. While some embryo models are regulated as embryos, others fall outside current legislation. The ethical justification for the 14-day rule is increasingly contested, with some scholars arguing that its original rationale does not align with contemporary scientific understanding. Available evidence suggests that Australians generally support embryo research under appropriate oversight, although recent data are limited and public views on extending the 14-day limit remain uncertain.

Conclusion:
Australia’s embryo research laws may not adequately reflect current scientific capabilities or societal expectations. A comprehensive Commonwealth review, supported by broad public consultation, is needed to clarify the legal status of SCEMs, reassess the 14-day rule, and ensure the regulatory framework remains ethically robust, scientifically informed, and publicly legitimate. To inform this review, an MRFF-funded project (#2046205) is conducting extensive regulatory and legal analyses, measuring public attitudes in a national survey and Citizens Jury, and engaging professional stakeholders in an online knowledge community.